Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+3.52M
-
Total reported value, excl. options
-
$635M
-
Value change
-
+$67.4M
-
Put/Call ratio
-
0
-
Number of buys
-
58
-
Number of sells
-
-29
-
Price
-
$19.80
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q4 2022
112 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q4 2022.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 132M outstanding shares and own 24.27% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.36M shares), FMR LLC (2.95M shares), Column Group LLC (2.68M shares), STATE STREET CORP (1.94M shares), BlackRock Inc. (1.9M shares), PERCEPTIVE ADVISORS LLC (1.8M shares), VANGUARD GROUP INC (1.51M shares), GREAT POINT PARTNERS LLC (1.44M shares), Deep Track Capital, LP (1.3M shares), and ORBIMED ADVISORS LLC (1.25M shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.